S17 Ep17: Localized Bladder Cancer 2026 UPDATE

About this episode

This episode provides a comprehensive review of localized bladder cancer, focusing on histology and treatment approaches.

Two Onc Docs , hosted by Samantha A. Armstrong, MD, and Karine Tawagi, MD, is a podcast dedicated to providing current and future oncologists and hematologists with the knowledge they need to ace their boards and deliver quality patient care. Dr Armstrong is a hematologist/oncologist and assistant professor of clinical medicine at Indiana University Health in Indianapolis. Dr Tawagi is a hematologist/oncologist and assistant professor of clinical medicine at the University of Illinois in Chicago. In this episode, OncLive On Air ® partnered with Two Onc Docs to provide a comprehensive review of localized bladder cancer, covering everything from initial histology to the rapidly evolving treatment paradigms for muscle-invasive disease. Drs Armstrong and Tawagi emphasized that although urothelial carcinoma remains the most common bladder cancer histology, recognizing variants like squamous, adenocarcinoma, and small cell is vital, as they often require surgery-first approaches or specialized chemotherapy. A critical diagnostic pearl highlighted for oncology boards was the necessity of muscularis propria in the transurethral resection of the bladder tumor (TURBT) specimen. If muscle…

People in this episode

Hosts: Samantha A. Armstrong, MD, Karine Tawagi, MD

Topics covered

• bladder cancer
• oncology
• treatment paradigms
• histology
• patient care

Keywords

• localized bladder cancer
• urothelial carcinoma
• muscle-invasive disease
• BCG induction
• TURBT

Mentioned in this episode

Organizations: Indiana University Health, University of Illinois

Books & works: OncLive On Air

Places: Indianapolis, Chicago

More episodes of OncLive® On Air

• S17 Ep32: Previewing Key Myeloma Presentations to Watch at EHA 2026: With Joshua Richter, MD · June 10, 2026 · 10 min
• S17 Ep31: ASCO 2026 Plenary: RASolute 302 · June 8, 2026 · 11 min
• S17 Ep30: Tumor Board: Clinical Integration of Molecular Profiling in Glioma—Transforming the Use of Targeted Therapy · June 5, 2026 · 32 min
• S17 Ep29: Navigating Radiation, Systemic Therapy, and Multidisciplinary Care in Skin Cancer: With Hirsch Matani, MD; Elizabeth Zhang-Velten, MD, PhD; and Binh T. Ngo, MD · June 1, 2026 · 30 min
• S17 Ep28: In-House Molecular Testing in NSCLC Improves Turnaround Time, Tissue Stewardship, and Multidisciplinary Coordination: Featuring Anthony Chi, MD; Monica Peravali, MD; and Archana Jadhav, MD · May 28, 2026 · 30 min
• S17 Ep27: Advances in Cervical Cancer: Prevention, Immunotherapy, and the Rise of Antibody-Drug Conjugates: With Ursula A. Matulonis, MD; and Meghan E. Shea, MD · May 27, 2026 · 16 min